The first surgeries in Europe using Stryker’s Gamma4 hip fracture nailing system have been successfully completed
The Gamma4 system is launched in Germany after more than 35 successful operations as part of a live broadcast
AMSTERDAM, Netherlands, May 29, 2024 –( BUSINESS WIRE )– Stryker (NYSE:SYK), a global leader in medical technology, announced that the first surgeries using the Gamma4 Hip Fracture Nailing System in Europe have been performed at the Lucerne Cantonal Hospital LUKS, the Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne, Switzerland, and the Hôpitaux Universitaires de Strasbourg in France. On June 4, 2024, Stryker will launch the system in Germany during a live broadcast , sharing key learnings and presenting case examples.
The Gamma4 Hip Fracture Nailing System is designed to treat hip and femoral neck fractures. Its nail design is based on Stryker’s SOMA database, which contains over 37,000 3D bone models generated from CT scans. The system received CE certification in November 2023 and has already been used in over 25,000 cases in North America and Japan.
“This moment is a significant milestone as the Gamma4 Hip Fracture Nailing System will now be available in the European market following its successful launch in the United States,” said Markus Ochs, Vice President and General Manager of Stryker’s European Trauma & Extremities Business. “This system demonstrates Stryker’s ongoing commitment to innovation and excellence in providing advanced medical solutions that provide surgeons around the world with options to optimize the surgical workflow and improve procedural efficiency.”
The first operations in Europe were carried out by:
- Professor Frank Beeres, Chief Physician, PD Dr. med. Björn-Christian Link, Chief Physician and Clinic Director, Dr. med. Marcel Köppel and Dr. med. Ralf Baumgärtner from the Lucerne Cantonal Hospital LUKS, Switzerland
- Professor Daniel Wagner, head of the Traumatology Unit and Doctor Kevin Moerenhout, Associate Doctor of the CHUV (Vaud University Hospital Centre) Lausanne, Switzerland
- Professor Philippe Adams Department at Les Hôpitaux Universitaires de Strasbourg, France
The Swiss surgeons agreed that Gamma4 allows for individual adaptation to the anatomy of each patient and improves surgical outcomes thanks to several important features. The system’s intuitive instrumentation optimizes procedures and reduces the number of surgical steps required. The surgeons particularly appreciated the precision fit of the implants and the high quality of the instruments.
Since these first use cases, over 35 additional operations have been performed using the Gamma4 system in France, Italy, the UK and Switzerland.
During the live broadcast on June 4, 2024 at 17:30 CET, Stryker will provide key information and a detailed insight into the Gamma4 development philosophy. Renowned experts, including Professor Dr. Gerhard Schmidmaier from Heidelberg University Hospital, Privatdozent Dr. Arvind G. Von Keudell from Copenhagen University Hospital and Professor Dr. Julio de Caso Rodríguez from Hospital de la Santa Creu i Sant Pau in Barcelona, will lead in-depth case discussions from trauma surgery. Interested healthcare professionals can register for the free event at worldsurgerytour.tv/programs/gamma4-european-premiere-broadcast .
For more information about the Gamma4 Hip Fracture Nailing System, visit stryker.com .
About Stryker
Stryker is a global leader in medical technology and is committed to working with its customers to improve healthcare. The company offers innovative MedSurg, Neurotechnology, Orthopedics and Spine products and services that help improve patient outcomes and healthcare. Together with its customers around the world, Stryker serves more than 150 million patients annually. For more information, visit www.stryker.com .
A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product in the treatment of a particular patient. Stryker does not provide medical advice and recommends that surgeons be trained in the use of a product before using it in surgery.
The information presented is intended to demonstrate the breadth of Stryker’s product offerings. A surgeon should always read the package insert, product label and/or instructions for use before using any of Stryker’s products. Products may not be available in all markets as product availability depends on regulatory and/or medical conditions in individual markets. Please contact your sales representative if you have any questions regarding product availability in your region.
Stryker Corporation, its divisions, or other affiliated companies own, use, or have applied for the following trademarks or service marks: Gamma4, Stryker. All other marks are trademarks of their respective owners or owners.
Copyright © 2024 Stryker
Content ID: G4-AD-15, 04-2024
The source language in which the original text is published is the official and authorized version. Translations are provided for ease of understanding. Only the language version that was originally published is legally binding. Therefore, compare translations with the original language version of the publication.
Contact
Sampson Public Relations Group
Andrea Sampson
President/CEO
asampson@sampsonprgroup.com
